Q: With the Caisse de depot acquiring a large US health care staffing company, do you see a potential in it buying PHA, a health care staffing company in its own backyard?
Q: Abbvie keeps getting sold off. Down another 2.5% today. Do you think it has bottomed after the steep slide over the past 10 days or so? Would this be a good entry point?
Q: I own both the above ETF’s, down approximately 33% on both. I am ready to be patient with them. Do you see any compelling reason in the cannabis market to keep holding them, or would you take your losses?
Thanks
Q: any idea why this co is trading so poorly. I know the share float is quite limited but has recently had insider buying and share buybacks. Looks like they have made some good acquisitions since IPO. Thanks
Q: thanks for Thursday's Market Update...the narrative and charts put reduced tapering with interest rate increases clearly in front of me...and now is making me wonder, especially about a possible window of opportunity later in the year, if I should wait until later to top up to full positions in ISRG and SYK, both heath care US stocks in a LIRA and to be held for the long-term, or do it now....what would you suggest I do or consider?.....oh, the funds used would move health care closer to the Portfolio Analytic target for this sector........thanks for the insights....Tom
Q: TRUL ... with recent activities and target stock prices from many brokerages between $96 to $85 ... is this undervalued and is this a good buy at this price
Q: hello 5i:
We've held GUD since 2014; one of the very few losers in a mostly, 5i recommended and diverse portfolio. Its shrunk to a less than 1% holding. Would you now be fine letting this go to add to a 1.5% position in WELL, realizing there may be a valuation difference? Thanks for your good work over the years. hello 5I:
just asked this question and should have included other health care holdings so you could assess properly. MRK, ABBV and VEEV in equal amounts. WELL at a smaller position. Please include this info with my previous question when answering.
thanks
Paul L
Paul L
Q: On 8/23 FDA gave final approval to PFE re vaccine,and PFE announced acquistion of Tril for $2.26B. Initial spike to $51.36 high,but been dropping since then to close at $46.04 today.Meanwhile C Wood has been buying. Is this a good time to buy? Txs for u usual great services & views
Q: Stocks not in your data base. I typed in ORMP, DVAX (a product similar to Moderna) and MAGS. When I did a search into questions asked - they advised no questions asked and to ask a question. ORMP I am up approx. 30% in a week. It is drug related. Can you give me some advice on these even if they are not in your data base?
Was looking for a good US name with some growth potential and a strong dividend and read your Aug 27 answer for John. Looked at ABBV today and it is down almost 9% and volume is almost triple the Average. In looking for news I have become confused after finding an Aug 26 article saying "AbbVie stock toppled after reporting its earnings." But it appears it didn't topple end of last week but rather, experienced the sharp decline today.
Should I be buying this on the dip? Or is there reasons to hold off for now? And if so, are there 3 other US names you might recommend which have good growth potential moving forward accompanied by a better than average dividend.
I hold WELL (2.5%) in my portfolio and keep eye on NBLY. Is it a overlap if I add NBLY? What price would you recommend to add NBLY based on it's current valuation?